This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Kayothera Inc., Princeton University. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 1,133 
Years Active: 2024
Title: John Piwinski: Innovator in Pharmaceutical Chemistry
Introduction
John Piwinski is a notable inventor based in Lebanon, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.
Latest Patents
Piwinski holds a patent for "Substituted heterocycles as aldehyde dehydrogenase inhibitors." This patent includes novel heterocyclic compounds, specifically compounds of Formula (IV-C). The patent also covers pharmaceutical compositions that utilize these compounds and methods for their application. These methods include inhibiting aldehyde dehydrogenases, activating the retinoid pathway, and treating various conditions such as cancers, cancer metastasis, type 2 diabetes, pulmonary arterial hypertension (PAH), neointimal hyperplasia (NIH), and even as a male contraceptive.
Career Highlights
Throughout his career, Piwinski has worked with prestigious institutions, including Princeton University and Kayothera Inc. His work has been instrumental in advancing the understanding and treatment of various medical conditions through innovative chemical solutions.
Collaborations
Piwinski has collaborated with notable professionals in his field, including John Robert Proudfoot and Yibin Kang. These collaborations have further enriched his research and contributed to the development of effective pharmaceutical applications.
Conclusion
John Piwinski's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for future developments in treatment options.